Virtual Reality for the Management of Pain and Anxiety in Patients Undergoing Implantation of Pacemaker or Implantable Cardioverter Defibrillator: A Randomized Study.
Connected devices
Defibrillator
Pacemaker
Pain management
Virtual reality
Journal
Journal of medical systems
ISSN: 1573-689X
Titre abrégé: J Med Syst
Pays: United States
ID NLM: 7806056
Informations de publication
Date de publication:
05 Mar 2024
05 Mar 2024
Historique:
received:
29
11
2023
accepted:
05
02
2024
medline:
5
3
2024
pubmed:
5
3
2024
entrez:
5
3
2024
Statut:
epublish
Résumé
The Virtual Reality Headset (VRH) is a device aiming at improving patient's comfort by reducing pain and anxiety during medical interventions. Its interest during cardiac implantable electronic devices (CIED) implant procedures has not been studied. We randomized consecutive patients admitted for pacemaker or Implantable Cardioverter Defibrillator (ICD) at our center to either standard analgesia care (STD-Group), or to VRH (VRH-Group). Patients in the STD-Group received intra-venous paracetamol (1 g) 60 min before the procedure, and local anesthesia was performed with lidocaine. For patients of the VRH-Group, VRH was used on top of standard care. We monitored patients' pain and anxiety using numeric rating scales (from 0 to 10) at the time of sub-cutaneous pocket creation, and during deep axillary vein puncture. Patient comfort during the procedure was assessed using a detailed questionnaire. Morphine consumption was also assessed. We randomized 61 patients to STD-Group (n = 31) or VRH-Group (n = 30). Pain and anxiety were lower in the VRH-Group during deep venous puncture (3.0 ± 2.0 vs. 4.8 ± 2.2, p = 0.002 and 2.4 ± 2.2 vs. 4.1 ± 2.4, p = 0.006) but not during pocket creation (p = 0.58 and p = 0.5). Morphine consumption was lower in the VRH-Group (1.6 ± 0.7 vs. 2.1 ± 1.1 mg; p = 0.041). Patients' overall comfort during procedure was similar in both groups. VRH use improved pain and anxiety control during deep venous puncture compared to standard analgesia care, and allowed morphine consumption reduction. However, pain and anxiety were similar at the time of sub-cutaneous pocket creation.
Sections du résumé
BACKGROUND
BACKGROUND
The Virtual Reality Headset (VRH) is a device aiming at improving patient's comfort by reducing pain and anxiety during medical interventions. Its interest during cardiac implantable electronic devices (CIED) implant procedures has not been studied.
METHODS
METHODS
We randomized consecutive patients admitted for pacemaker or Implantable Cardioverter Defibrillator (ICD) at our center to either standard analgesia care (STD-Group), or to VRH (VRH-Group). Patients in the STD-Group received intra-venous paracetamol (1 g) 60 min before the procedure, and local anesthesia was performed with lidocaine. For patients of the VRH-Group, VRH was used on top of standard care. We monitored patients' pain and anxiety using numeric rating scales (from 0 to 10) at the time of sub-cutaneous pocket creation, and during deep axillary vein puncture. Patient comfort during the procedure was assessed using a detailed questionnaire. Morphine consumption was also assessed.
RESULTS
RESULTS
We randomized 61 patients to STD-Group (n = 31) or VRH-Group (n = 30). Pain and anxiety were lower in the VRH-Group during deep venous puncture (3.0 ± 2.0 vs. 4.8 ± 2.2, p = 0.002 and 2.4 ± 2.2 vs. 4.1 ± 2.4, p = 0.006) but not during pocket creation (p = 0.58 and p = 0.5). Morphine consumption was lower in the VRH-Group (1.6 ± 0.7 vs. 2.1 ± 1.1 mg; p = 0.041). Patients' overall comfort during procedure was similar in both groups.
CONCLUSION
CONCLUSIONS
VRH use improved pain and anxiety control during deep venous puncture compared to standard analgesia care, and allowed morphine consumption reduction. However, pain and anxiety were similar at the time of sub-cutaneous pocket creation.
Identifiants
pubmed: 38441786
doi: 10.1007/s10916-024-02039-1
pii: 10.1007/s10916-024-02039-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
28Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Banks H, Torbica A, Valzania C, Varabyova Y, Prevolnik Rupel V, Taylor RS, Hunger T, Walker S, Boriani G, Fattore G. Five year trends (2008–2012) in cardiac implantable electrical device utilization in five european nations: A case study in cross-country comparisons using administrative databases. Europace. 2018;20:643–653
doi: 10.1093/europace/eux123
pubmed: 29016747
Li A, Montaño Z, Chen VJ, Gold JI. Virtual reality and pain management: Current trends and future directions. Pain management. 2011;1:147–157
doi: 10.2217/pmt.10.15
pubmed: 21779307
Hitching R, Hoffman HG, Garcia-Palacios A, Adamson MM, Madrigal E, Alhalabi W, Alhudali A, Sampaio M, Peterson B, Fontenot MR, Mason KP. The emerging role of virtual reality as an adjunct to procedural sedation and anesthesia: A narrative review. Journal of clinical medicine. 2023;12
Indovina P, Barone D, Gallo L, Chirico A, De Pietro G, Giordano A. Virtual reality as a distraction intervention to relieve pain and distress during medical procedures: A comprehensive literature review. The Clinical journal of pain. 2018;34:858–877
doi: 10.1097/AJP.0000000000000599
pubmed: 29485536
Bruno RR, Lin Y, Wolff G, Polzin A, Veulemans V, Klein K, Westenfeld R, Zeus T, Kelm M, Jung C. Virtual reality-assisted conscious sedation during transcatheter aortic valve implantation: A randomised pilot study. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2020;16:e1014-e1020
doi: 10.4244/EIJ-D-20-00269
pubmed: 32597390
Roxburgh T, Li A, Guenancia C, Pernollet P, Bouleti C, Alos B, Gras M, Kerforne T, Frasca D, Le Gal F, Christiaens L, Degand B, Garcia R. Virtual reality for sedation during atrial fibrillation ablation in clinical practice: Observational study. Journal of medical Internet research. 2021;23:e26349
doi: 10.2196/26349
pubmed: 34042589
pmcid: 8193475
Jung C, Wolff G, Wernly B, Bruno RR, Franz M, Schulze PC, Silva JNA, Silva JR, Bhatt DL, Kelm M. Virtual and augmented reality in cardiovascular care: State-of-the-art and future perspectives. JACC Cardiovasc Imaging. 2022;15:519–532
doi: 10.1016/j.jcmg.2021.08.017
pubmed: 34656478
Hermans ANL, Betz K, Verhaert DVM, den Uijl DW, Clerx K, Debie L, Lahaije M, Vernooy K, Linz D, Weijs B. 360° virtual reality to improve patient education and reduce anxiety towards atrial fibrillation ablation. Europace. 2023;25:855–862
doi: 10.1093/europace/euac246
pubmed: 36738261
pmcid: 10062331
Pereira PJS, Lerner EA. Gate control theory springs a leak. Neuron. 2017;93:723–724
doi: 10.1016/j.neuron.2017.02.016
pubmed: 28231458
pmcid: 5474310
Lind A, Ahsan M, Totzeck M, Al-Rashid F, Haddad A, Dubler S, Brenner T, Skarabis A, El Gabry M, Rassaf T, Jánosi RA. Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study. Int J Cardiol. 2023;387:131130
doi: 10.1016/j.ijcard.2023.131130
pubmed: 37355243
Smith V, Warty RR, Sursas JA, Payne O, Nair A, Krishnan S, da Silva Costa F, Wallace EM, Vollenhoven B. The effectiveness of virtual reality in managing acute pain and anxiety for medical inpatients: Systematic review. Journal of medical Internet research. 2020;22:e17980
doi: 10.2196/17980
pubmed: 33136055
pmcid: 7669439
Weech S, Kenny S, Barnett-Cowan M. Presence and cybersickness in virtual reality are negatively related: A review. Frontiers in psychology. 2019;10:158
doi: 10.3389/fpsyg.2019.00158
pubmed: 30778320
pmcid: 6369189